CYRX Cryoport Inc

Price (delayed)

$21.65

Market cap

$1.05B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.93

Enterprise value

$1.44B

Cryoport, Inc. is redefining temperature-controlled supply chain support for the life sciences industry by continually broadening its platform of solutions, serving the Biopharma, Reproductive Medicine, and Animal Health markets. Through ...

Highlights
The company's net income has surged by 87% QoQ and by 86% YoY
Cryoport's EPS has soared by 85% from the previous quarter and by 85% YoY
Cryoport's equity has decreased by 13% YoY
The quick ratio has declined by 11% year-on-year

Key stats

What are the main financial stats of CYRX
Market
Shares outstanding
48.34M
Market cap
$1.05B
Enterprise value
$1.44B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.91
Price to sales (P/S)
4.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.09
Earnings
Revenue
$237.28M
EBIT
-$28.95M
EBITDA
-$6.19M
Free cash flow
-$25.43M
Per share
EPS
-$0.93
Free cash flow per share
-$0.52
Book value per share
$11.34
Revenue per share
$4.84
TBVPS
$14.22
Balance sheet
Total assets
$1.04B
Total liabilities
$482.91M
Debt
$435.91M
Equity
$555.84M
Working capital
$563.33M
Liquidity
Debt to equity
0.78
Current ratio
14.79
Quick ratio
13.91
Net debt/EBITDA
-64.38
Margins
EBITDA margin
-2.6%
Gross margin
43.8%
Net margin
-15.7%
Operating margin
-13.4%
Efficiency
Return on assets
-4.3%
Return on equity
-7.9%
Return on invested capital
-2.8%
Return on capital employed
-2.9%
Return on sales
-12.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CYRX stock price

How has the Cryoport stock price performed over time
Intraday
0.14%
1 week
-5.38%
1 month
5.1%
1 year
-34.98%
YTD
24.78%
QTD
24.78%

Financial performance

How have Cryoport's revenue and profit performed over time
Revenue
$237.28M
Gross profit
$103.87M
Operating income
-$31.9M
Net income
-$37.33M
Gross margin
43.8%
Net margin
-15.7%
The company's net income has surged by 87% QoQ and by 86% YoY
The net margin has soared by 87% YoY and by 87% from the previous quarter
Cryoport's operating income has plunged by 79% YoY and by 9% from the previous quarter
Cryoport's operating margin has shrunk by 68% YoY and by 7% QoQ

Growth

What is Cryoport's growth rate over time

Valuation

What is Cryoport stock price valuation
P/E
N/A
P/B
1.91
P/S
4.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.09
Cryoport's EPS has soared by 85% from the previous quarter and by 85% YoY
CYRX's price to book (P/B) is 71% less than its 5-year quarterly average of 6.7 and 17% less than its last 4 quarters average of 2.3
Cryoport's equity has decreased by 13% YoY
CYRX's P/S is 75% below its 5-year quarterly average of 18.0 and 23% below its last 4 quarters average of 5.8
The revenue rose by 7% year-on-year

Efficiency

How efficient is Cryoport business performance
The company's return on invested capital has surged by 93% YoY and by 90% QoQ
Cryoport's ROS has soared by 90% from the previous quarter and by 90% YoY
The return on assets has surged by 86% year-on-year and by 84% since the previous quarter
CYRX's return on equity has surged by 84% since the previous quarter and by 82% year-on-year

Dividends

What is CYRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CYRX.

Financial health

How did Cryoport financials performed over time
The total assets is 115% more than the total liabilities
The quick ratio has declined by 11% year-on-year
The current ratio has contracted by 9% YoY
The debt is 22% less than the equity
The debt to equity is up by 16% year-on-year
Cryoport's equity has decreased by 13% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.